← Open Payments lookup

JONATHAN CORREN: Open Payments

NPI 1447360086 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$74,318 in 131 payments from 26 companies in 2025. Trend: 2023 $97,826 · 2024 $58,518 · 2025 $74,318

Speaker / faculty: $50,696Consulting: $18,425Food & beverage: $2,617Travel & lodging: $2,580
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP33$35,852
Regeneron Healthcare Solutions, Inc.11$14,699
GENZYME CORPORATION17$12,528
GlaxoSmithKline, LLC.9$3,879
Amgen Inc.5$3,278
Eli Lilly and Company4$2,275
ABBVIE INC.1$550
CSL Behring11$171
Novartis Pharmaceuticals Corporation6$158
PFIZER INC.8$158

Products named: TEZSPIRE, DUPIXENT, Hizentra, CIBINQO, NUCALA, Rhapsido, ORLADEYO, Xolair.

Industry payments across CA — which companies pay providers there.